How long has repatha been on the market?

How long has Repatha (evolocumab) been available to patients?

Repatha has been on the market since 2015, when it received FDA approval for the treatment of high cholesterol. That means it has been commercially available for about 11 years as of 2026.

When did Repatha first get FDA approval?

Repatha’s FDA approval dates to 2015, which is the key milestone used to measure how long it has been on the market.

What counts as “on the market” for this kind of question?

For most buyers and patients, “on the market” usually means FDA approval and subsequent commercial launch in the U.S., rather than earlier clinical trial use. The year 2015 is the relevant reference point for Repatha.

Are there later approvals that changed its use?

Repatha’s initial approval in 2015 has been followed by additional indications over time, but the start of market availability is still tied to that first FDA approval year.

Source

• [1] DrugPatentWatch.com: https://www.drugpatentwatch.com